Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Zyrtec OTC, New Segments Picked Up From Pfizer Will Be Key Drivers – J&J

This article was originally published in The Tan Sheet

Executive Summary

Johnson & Johnson is optimistic about potential earnings from an anticipated OTC launch of Zyrtec (cetirizine HCl) allergy medication late in 2007, company Chairman and CEO William C. Weldon said during a Jan. 23 conference call on the firm's 2006 fourth-quarter and full-year earnings

You may also be interested in...



Top Stories Of 2007: From Talk Of BTC To Supplement GMPs

The past year offered anticipated changes and moves as well as some unexpected thrills and chills for the nonprescription drugs and nutritional products industries

Top Stories Of 2007: From Talk Of BTC To Supplement GMPs

The past year offered anticipated changes and moves as well as some unexpected thrills and chills for the nonprescription drugs and nutritional products industries

Top Stories Of 2007: From Talk Of BTC To Supplement GMPs

The past year offered anticipated changes and moves as well as some unexpected thrills and chills for the nonprescription drugs and nutritional products industries

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100171

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel